The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Fulminant hepatic failure: Summary of a workshop
Abstract
Fulminant hepatic failure (FHF) is defined by the appearance of severe liver injury with hepatic encephalopathy in a previously healthy person. There are an estimated 2,000 cases of FHF in the United States yearly, representing 0.1% of all deaths and, perhaps, 6% of liverrelated deaths. The causes of FHF are many, the chief ones in the United States being hepatitis A; B; non-A, non-B and drug induced liver disease. There are no specific therapies for FHF, however, liver transplantation is recommended for situations in which spontaneous recovery appears unlikely. Factors that are valuable in assessing the likelihood of spontaneous recovery are static features such as patient age and etiology of FHF and dynamic features including encephalopathy grade, prothrombin time, and serum bilirubin. Presently, approximately 7% of all liver transplants are done for FHF and the 1-year patient survival rates average 63%, somewhat less than survival rates for nonfulminant liver disease, averaging 78%. The management of patients with FHF is challenging, particularly important being monitoring and early treatment of infections, hemodynamic abnormalities, and brain edema. Innovative approaches to management and therapy include use of cytoprotective or antiviral medications, hepatic support systems, extracorporeal liver support, hepatocyte transplantation, auxiliary liver transplantation, and xenotransplantation. None of these are of proven benefit, but many are promising as a means to support the patient with FHF until spontaneous recovery occurs or a suitable liver graft is available for transplantation. (Hepatology 1995;21:240-252).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2012) · Hepatogastroenterology · doi:10.5754/hge12469 · Cited by 3,178
Early indicators of prognosis in fulminant hepatic failure
O'Grady, J. G., Alexander, G. J. M., Hayllar, K. M., & Williams, R. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90081-4 · Cited by 2,085
The Natural History of Community-Acquired Hepatitis C in the United States
Alter, M. J., Margolis, H. S., Krawczynski, K., Judson, F. N., Mares, A., Alexander, W. J., Hu, P. Y., Miller, J. K., Gerber, M. A., Sampliner, R. E., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272702 · Cited by 1,592
National Hospital Discharge Survey, 1988: Archival Version
United States Department of Health and Human Services. National Center for Health Statistics (1991) · ICPSR Data Holdings · doi:10.3886/icpsr09521 · Cited by 1,310
Improvement by Acetylcysteine of Hemodynamics and Oxygen Transport in Fulminant Hepatic Failure
Harrison, P. M., Wendon, J. A., Gimson, A. E. S., Alexander, G. J. M., & Williams, R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199106273242604 · Cited by 585
Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease
Todo, S., Demetris, A. J., van Thiel, D., Teperman, L., Fung, J. J., & Starzl, T. E. (1991) · Hepatology · doi:10.1002/hep.1840130402 · Cited by 565
Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure
O'Grady, J. G., Gimson, A. E. S., O'Brien, C. J., Pucknell, A., Hughes, R. D., & Williams, R. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90011-x · Cited by 538
Omata, M., Ehata, T., Yokosuka, O., Hosoda, K., & Ohto, M. (1991) · New England Journal of Medicine · doi:10.1056/nejm199106133242404 · Cited by 523
Multivariate analysis of prognostic factors in fulminant hepatitis B
Bernuau, J., Goudeau, A., Poynard, T., Dubois, F., Lesage, G., Yvonnet, B., Degott, C., Bezeaud, A., Rueff, B., & Benhamou, J.-P. (1986) · Hepatology · doi:10.1002/hep.1840060417 · Cited by 501
Keays, R., Harrison, P. M., Wendon, J. A., Forbes, A., Gove, C., Alexander, G. J., & Williams, R. (1991) · BMJ · doi:10.1136/bmj.303.6809.1026 · Cited by 488
Baboon-to-human liver transplantation
Starzl, T. E., Fung, J., Tzakis, A., Todo, S., Demetris, A. J., Marino, I. R., Doyle, H., Zeevi, A., Warty, V, Kusne, S., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)92553-6 · Cited by 471
Baboon-to-Human Cardiac Xenotransplantation in a Neonate
Bailey, L. L. (1985) · JAMA · doi:10.1001/jama.1985.03360230053022 · Cited by 458
Alter, M. J. (1990) · JAMA · doi:10.1001/jama.263.9.1218 · Cited by 458
Long-Term Improvement of Hypercholesterolemia After Ex Vivo Gene Therapy in LDLR-Deficient Rabbits
Chowdhury, J. R., Grossman, M., Gupta, S., Chowdhury, N. R., Baker, J. R., & Wilson, J. M. (1991) · Science · doi:10.1126/science.1722351 · Cited by 366
Reversal of Fulminant Hepatic Failure Using An Extracorporeal Liver Assist Device
Sussman, N. L., Chong, M. G., Koussayer, T., He, D.-E., Shang, T. A., Whisennand, H. H., & Kelly, J. H. (1992) · Hepatology · doi:10.1002/hep.1840160112 · Cited by 345
Renal Heterotransplmtation in Man
REEMTSHA, K., MCCRACKEN, B. H., & SCHEGEL, J. U. (1964) · Annals of Surgery · doi:10.1097/00000658-196409000-00006 · Cited by 332
Prospective Study of Bacterial Infection in Acute Liver Failure: An Analysis of Fifty Patients
Rolando, N., Harvey, F., Brahm, J., Philpott-Howard, J., Alexander, G., Gimson, A., Casewell, M., Fagan, E., & Williams, R. (1990) · Hepatology · doi:10.1002/hep.1840110110 · Cited by 323
Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure.
Canalese, J., Gimson, A. E., Davis, C., Mellon, P. J., Davis, M., & Williams, R. (1982) · Gut · doi:10.1136/gut.23.7.625 · Cited by 306
Replacement of Liver Function in Rats by Transplantation of Microcarrier-Attached Hepatocytes
Demetriou, A. A., Whiting, J. F., Feldman, D., Levenson, S. M., Chowdhury, N. R., Moscioni, A. D., Kram, M., & Chowdhury, J. R. (1986) · Science · doi:10.1126/science.2426782 · Cited by 294
Treatment of Hepatic Failure with ex Vivo Pig-Liver Perfusion Followed by Liver Transplantation
Chari, R. S., Collins, B. H., Magee, J. C., DiMaio, J. M., Kirk, A. D., Harland, R. C., McCann, R. L., Platt, J. L., & Meyers, W. C. (1994) · New England Journal of Medicine · doi:10.1056/nejm199407283310404 · Cited by 286
Rozga, J., Williams, F., Ro, M.-S., Neuzil, D. F., Giorgio, T. D., Backfisch, G., Moscioni, A. D., Hakim, R., & Demetriou, A. A. (1993) · Hepatology · doi:10.1002/hep.1840170216 · Cited by 276
Complications of intracranial pressure monitoring in fulminant hepatic failure
Blei, A. T., Olafsson, S., Webster, S., & Levy, R. (1993) · The Lancet · doi:10.1016/0140-6736(93)90016-a · Cited by 270
Swain, M., Butterworth, R. F., & Blei, A. T. (1992) · Hepatology · doi:10.1002/hep.1840150316 · Cited by 263
Inhibition of brain glutamine accumulation prevents cerebral edema in hyperammonemic rats
Takahashi, H., Koehler, R. C., Brusilow, S. W., & Traystman, R. J. (1991) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1991.261.3.h825 · Cited by 262
Transplantation of microcarrier-attached hepatocytes into 90% partially hepatectomized rats
Demetriou, A. A., Reisner, A., Sanchez, J., Levenson, S. M., Moscioni, A. D., & Chowdhury, R. J. (1988) · Hepatology · doi:10.1002/hep.1840080505 · Cited by 211
Liver Transplantation for Fulminant Hepatic Failure
Ascher, N. L. (1993) · Archives of Surgery · doi:10.1001/archsurg.1993.01420180079015 · Cited by 195
Self-citationGubernatis, G., Pichlmayr, R., Kemnitz, J., & Gratz, K. (1991) · World Journal of Surgery · doi:10.1007/bf01789221 · Cited by 192
Rolando, N., Gimson, A., Wade, J., Philpott-Howard, J., Casewell, M., & Williams, R. (1993) · Hepatology · doi:10.1002/hep.1840170206 · Cited by 184
Hepatitis B virus and apparent fulminant non-A, non-B hepatitis
Wright, T. L., Mamish, D., Combs, C., Kim, M., Wright, T. L., Mamish, D., Combs, C., Kim, M., Lake, J., Donegan, E., et al. (1992) · The Lancet · doi:10.1016/0140-6736(92)91530-l · Cited by 163
Self-citationRolando, N. (1993) · Hepatology · doi:10.1016/0270-9139(93)90076-y · Cited by 149
HAMSTER-TO-RAT HEART AND LIVER XENOTRANSPLANTATION WITH FK506 PLUS ANTIPROLIFERATIVE DRUGS
Murase, N., Starzl, T. E., Demetris, A. J., Valdivia, L. A., Tanabe, M., Cramer, D. V., & Makowka, L. (1993) · Transplantation · doi:10.1097/00007890-199304000-00003 · Cited by 147
Investigating the painful swollen calf.
Gompels, B. M., & Darlington, L. G. (1980) · PubMed · Cited by 119
Clinical monitoring of intracranial pressure in fulminant hepatic failure.
Hanid, M. A., Davies, M., Mellon, P. J., et al. (1980) · Gut · doi:10.1136/gut.21.10.866 · Cited by 106
Hepatology: A Textbook of Liver Disease
Iber, F. L. (1990) · JAMA · doi:10.1001/jama.1990.03450130129042 · Cited by 100
INTERFERON SYSTEM IN ACUTE VIRAL HEPATITIS
Levin, S., & Hahn, T. (1982) · The Lancet · doi:10.1016/s0140-6736(82)91751-2 · Cited by 88
Human liver cell transplantation
Moscioni, A. D., Roy‐Chowdhury, J., Barbour, R. L., Brown, L. L., Roy‐Chowdhury, N., Competiello, L. S., Lahiri, P., & Demetriou, A. A. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90525-8 · Cited by 78
Etiology of fulminant hepatic failure: Is another virus involved?
Wright, T. L. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90437-h · Cited by 58
Artificial liver: State of the art
Takahashi, T., Malchesky, P. S., & Nos�, Y. (1991) · Digestive Diseases and Sciences · doi:10.1007/bf01307531 · Cited by 47
Cited by
Food-Related Illness and Death in the United States
Mead, P. S., Slutsker, L., Dietz, V., McCaig, L. F., Bresee, J. S., Shapiro, C., Griffin, P. M., & Tauxe, R. V. (1999) · Emerging Infectious Diseases · doi:10.3201/eid0505.990502 · Cited by 7,235
Self-citationOstapowicz, G., Fontana, R. J., Schiødt, F. V., Larson, A., Davern, T. J., Han, S. H. B., McCashland, T. M., Shakil, A. O., Hay, J. E., Hynan, L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-12-200212170-00007 · Cited by 2,227
Hepatitis B: The virus and disease #
Liang, J. T. (2009) · Hepatology · doi:10.1002/hep.22881 · Cited by 1,061
AASLD position paper: The management of acute liver failure†
Polson, J., & Lee, W. M. (2005) · Hepatology · doi:10.1002/hep.20703 · Cited by 974
Hepatitis C: the clinical spectrum of disease.
Hoofnagle, J. H. (1997) · Hepatology · doi:10.1002/hep.510260703 · Cited by 765
Metadata
- Authors
- Hoofnagle, J. H., Carithers, R. L., Shapiro, C., & Ascher, N.
- Venue
- Hepatology
- Published
- 1995-01
- Volume
- 21
- Issue
- 1
- Pages
- 240-252
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1998185410
- Cited by
- 533
- References
- 38
- FWCI
- 16.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.